Primary ovarian carcinomas and abdominal metastasis contain 4,6-disulfated chondroitin sulfate rich regions, which provide adhesive properties to tumour cells by Vallen, M.J.E. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/136032
 
 
 
Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
Primary Ovarian Carcinomas and Abdominal Metastasis
Contain 4,6-Disulfated Chondroitin Sulfate Rich Regions,
Which Provide Adhesive Properties to Tumour Cells
Myrtille J. E. Vallen1,2*, Samuel Schmidt3, Arie Oosterhof1, Johan Bulten4, Leon F. A. G. Massuger2,
Toin H. van Kuppevelt1
1Department of Biochemistry, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands, 2Department of Obstetrics
and Gynaecology, Radboud University Medical Center, Nijmegen, The Netherlands, 3Department of Cell Biology, Nijmegen Center for Molecular Life Sciences, Radboud
University Medical Center, Nijmegen, The Netherlands, 4Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands
Abstract
High mortality in ovarian cancer patients is primarily caused through rapid metastasis of the tumour, but the underlying
mechanisms are poorly understood. Glycosaminoglycans, are abundantly present in tumours and chondroitin sulfate-E
(CSE), a highly 4,6-sulfated glycosaminoglycan, has been indicated to play a role in carcinogenesis. In this study we
investigated the presence of CSE in ovarian cancer metastasis and studied its role in tumour cell adhesiveness and
migration. CSE was studied immunohistochemically in primary ovarian carcinomas and abdominal metastases using the
single chain antibody GD3G7. The role of CSE was studied in 2D (scratch assays) and 3D (collagen matrices, spheroids)
systems using SKOV3 cells applying 1: overexpression of CSE by stable transfection with DNA encoding GalNAc4S-6
sulfotransferase, 2: enzymatic removal of CS, and 3: addition of CSE. In ovarian cancer tissue, CSE expression was
predominantly seen in the stromal compartment of both primary ovarian carcinomas and metastases, with a comparable
degree of intensity and extent. Overexpression of CSE disaccharide units by tumour cells increased their adhesive properties
which was especially seen in tumour spheroid formation. Increased expression of CSE reduced cell migration. Addition of
free CSE had similar effects. The data presented here indicate that CSE is associated with metastatic lesions and that it
provides tumours with adhesive properties. CSE rich motifs are put forward as a potential target for ovarian cancer therapy.
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Introduction
Ovarian cancer is the fifth leading cause of cancer death in
women worldwide. Each year this disease accounts for approxi-
mately 225,000 new patients and 140,000 deaths [1]. Despite
advances in cytoreductive surgery and modern chemotherapy,
five-year survival rates are not improving. This high lethality is
primarily due to the fact that patients are diagnosed with advanced
stage disease (FIGO III–IV), when the tumour is already widely
spread [2,3]. Unlike other tumours, haematogenous dissemination
of ovarian cancer cells is rare. Instead, ovarian carcinomas mainly
disseminate via the transcoelomic route. Tumour cells and cell
aggregates (spheroids) are shed from the primary tumour into the
peritoneal space, where they preferably seed and attach to the
peritoneum and omentum [4,5].
In order for ovarian cancer cells to establish metastatic
depositions, they need to aggregate and attach to the mesothelial
lining. These initial steps in ovarian cancer progression are still
poorly understood [6] and only little is known about the molecules
involved in ovarian cancer cell adhesion [7]. There is increasing
evidence that molecules in the extracellular matrix (ECM) play a
crucial role in adhesiveness, and that the tumour stroma is a key
player in this respect. It has been indicated that tumour cells may
even bring their own soil, thereby providing a specific tumour
niche and facilitating metastasis [8].
The ECM is a highly organized three-dimensional structure
which maintains tissue integrity and is actively involved in many
important physiological and pathological processes e.g. the
binding of growth factors and adapting mechanical properties
[9]. Tumour cells are known to interfere with the normal
biosynthesis of the ECM and as a consequence modify its
biochemical composition [10]. Proteoglycans and glycosamino-
glycans are major constituents of the ECM and the cell
membrane, mediating cell-cell and cell-matrix interactions.
Proteoglycans are a complex group of glycoproteins, which
contain a core protein with one or more covalently bound sulfated
glycosaminoglycan chains. Based on the chemical backbone of
glycosaminoglycans a number of classes can be discerned
including dermatan sulfate (DS)/chondroitin sulfate (CS), heparan
sulfate (HS)/heparin and keratan sulfate (KS). Hyaluronan (HA) is
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a special class of glycosaminoglycans not bound to a protein core.
Normal ovary contains large amounts of DS [11,12], however,
during ovarian carcinogenesis the predominant glycosaminogly-
can reverts to CS [13], a phenomenon seen in various types of
cancer [14,15]. Within the class of CS a large heterogeneity exists
due to the presence of differently sulfated disaccharide units
including CSA (4-sulfated), CSC (6-sulfated), CSD (2,6-disulfated)
and CSE (4,6-disulfated). In cancerous tissue alterations in the
sulfation level and type of the disaccharide units have been
observed [16–21].
Using an antibody recognizing a motif that is rich in CSE units
(GD3G7), we recently showed strong upregulation of CSE in primary
ovarian carcinomas which correlated with poor prognostic parameters
such as high grade, and advanced FIGO stage [19]. Interference with
CSE, either by blockage using GD3G7 or by enzymatic degradation
of CS chains, strongly inhibited metastatic growth in a mouse Lewis
lung carcinoma model [22]. In addition, murine osteosarcoma cells
containing high levels of CSE formed more metastatic liver tumour
nodules compared to cells with lower levels, an effect that could be
inhibited by preincubation of cells with the GD3G7 antibody or by
preadministration with CS rich in CSE units [23].
The final step in the biosynthesis of the CSE subunit depends on
the enzyme N-acetyl galactosamine 4-sulfate 6-O-sulfotransferase
(GalNAc4S-6ST), which forms CSE by transferring an additional
sulfate group to CSA [24]. An increase of GalNAc4S-6ST mRNA
has been observed in patients with colorectal and astrocytic tumours
[25,26]. In astrocytic tumours elevated levels of GalNAc4S-6ST
mRNA correlated with poor patient outcome. Down regulation of
the expression of GalNAc4S-6ST in a Lewis lung carcinoma cell
line resulted in reduced adhesiveness of cells to ECMmolecules and
suppression of metastatic lung carcinoma [27].
In this study, we first examined CSE expression in primary
ovarian carcinomas and ovarian metastasis in the peritoneal
cavity. We then addressed the mechanistic role of CSE, a.o. by
establishing SKOV3 cell lines stably transfected with DNA
encoding GalNAc4S-6ST and studying adhesiveness and cell
migration using 2D and 3D model systems.
Materials and Methods
Human tumour tissue and cell lines
Paraffin embedded tumour material from 25 ovarian cancer
patients (serous subtype) was obtained from the archives of the
Department of Pathology at Radboud University Medical Centre.
From all patients we collected representative tumour slides
including primary carcinoma and abdominal metastases (omental
and peritoneal tumour depositions). All slides were reviewed by an
experienced gyneco-pathologist (JB) using H&E sections. The age
at diagnosis, CA125 level at diagnosis, menopausal status, FIGO
stage [28], tumour grade [29] and primary debulking result
(defined as complete or incomplete) were recorded (Table 1).
The human ovarian cancer SKOV3 cell line was generously
provided by Dr. L.G. Poels (Radboud University Medical Center).
Originally this SKOV3 cell line was obtained from the American
Type Culture Collection (ATCC,Manassas, VA). Cells were cultured
and maintained in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal calf serum (FCS) (Life Technologies
Paisley, UK) and penicillin/streptomycin (100 U/ml). Cells were
incubated in a humidified atmosphere containing 5% CO2 at 37uC.
Immunohistochemistry
Five mm paraffin sections were immunohistochemically analysed
according to the ABC-method as described previously [19]. In
brief, sections were de-paraffinised in xylene, hydrated with
graded ethanol and blocked for endogenous peroxidase activity.
After rinsing in phosphate-buffered saline (PBS) containing 0.1%
Tween-20 (PBS-T), sections were incubated in 0.1 M citrate buffer
(pH 5.8) and blocked with 2% bovine serum albumin (BSA,
fraction V, Sigma-Aldrich) in PBS-T. Next, sections were
incubated successively with primary anti-CS antibodies, secondary
mouse anti-VSV antibody P5D4, and tertiary biotinylated horse-
anti-mouse IgG (Vector Laboratories Inc.). After incubation with
ABC-reagents (Vectastain ABC anti-mouse-IgG kit, Vector
Laboratories Inc.), bound antibodies were detected using 3-
amino-9-ethylcarbazole (AEC). Sections were counterstained with
haematoxylin and mounted with Kaiser’s glycerol gelatin (Merck,
Darmstadt, Germany). Different single chain CS-antibodies were
applied, including IO3H10 (overall staining for CS) [30], GD3A12
(staining for dermatan sulfate) [11], and GD3G7 (staining for 4,6-
disulfated CS (CSE)) [31].
For immunofluorescence of SKOV3 cell lines, cells were plated
on 10-wells glass slides (Nutacon, Portsmouth, NH) and grown to
confluency. Cells were washed with PBS and fixed with 100% ice
cold methanol. After blocking with PBS-T and 1% BSA, sections
were incubated with primary antibody for 60 min. Bound
antibodies were detected by secondary anti-VSV tag mouse
antibody P5D4 and visualized by a tertiary antibody step including
goat antimouse IgG Alexa Fluor 488 (Invitrogen, Paisley, Scot-
land), Finally, cryosections were fixed in 100% ethanol, air-dried
and mounted in mowiol-488 (Calbiochem, La Jolla, CA).
Generation of stably transfected SKOV-3 cell lines with
DNA encoding for GalNAc4S-6ST
pFLAG-CMV2-hGalNAc4S-6ST, generously provided by Prof.
Osami Habuchi, (Kariya, Japan), pBluescript SK II (Stratagene,
La Jolla, USA) and pIRES-EGFP (Invitrogen, Paisley, Scotland)
were used to construct the pIRES2-EGFP-GalNAc4S-6ST plas-
mid. An intermediate step was incorporated in the cloning
procedure to generate compatible restriction sites (S. 1). Restric-
tion enzymes EcoRI, HindIII and Xhol were purchased from New
England Biolabs, Beverly, MA. Transfection of the SKOV3 was
performed using LipofectamineTM 2000 (Invitrogen, San Diego,
CA) according to the manufacturer’s protocol. Geneticine G418
(Invitrogen, San Diego, CA) resistant cell clones were isolated and
expanded for further characterization. For comparative purposes
we selected two clones (C5 and C6) containing an empty vector
(pIRES2-EGFP(-)) and three clones (F5, F7 and F9) with full vector
(pIRES2-EGFP-GalNAc4S-6ST).
To establish the incorporation of the pIRES2-EGFP-Gal-
NAc4S-6ST into genomic DNA, total genomic DNA was isolated
from SKOV3 cells using a Qiagen AllPrep DNA/RNA micro kit
(Qiagen GmbH, Hilden, Germany) according to manufacturer’s
specifications. The concentration of DNA was determined using a
Nanodrop 2000c spectrophotometer (NanoDrop products, Wil-
mington, DE, USA). Primer sets covering exon-exon boundaries
were designed using Primer 3 [32] based on the reference
sequence obtained from the UCSC human genome browser
(http://genome.ucsc.edu/), assembly February 2009 (GRCh37/
hg19). Two primer sets for human GalNAc4S-6ST and 1 for the
housekeeping gene human acidic ribosomal phosphoprotein P0
(RPLP0) were used (Biolegio (Nijmegen, The Netherlands). The
primer sequences were as follow: hGalNAc4S-6ST, 59-GACG-
CAGGACTTCATCCAC-‘3 (forward), 59-AGCAACAGTTT-
CTCATTCTTCG-‘3 (forward), 59GCGGATTTATTCGAA-
CTTGC-‘3 (reverse) and 59-ATCAAAGCCTCCTGCTTCTC-
‘3 (reverse), and for RPLP0, 59-CACCATTGAAATCCTGAGT-
GATGT-‘3 (forward) and 59-TGACCAGCCCAAAGGAGAAG-
93 (reverse). Real-Time quantitative polymerase chain reaction
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(QPCR) was carried out with 5 ng DNA, using CFX Real Time
PCR detection system and Bio-Rad CFX manager software
version 1.6 for quantification with Sybr Green and melting curve
analysis (Bio-Rad Laboratories, Inc., Hercules, CA). Amplifica-
tions were performed starting with a 10 min template denatur-
ation step at 95uC, followed by 40 cycles of denaturation at 95uC
for 15 s and combined primer annealing/extension at 60uC for
60 s.
Reverse phase-high performance liquid chromatography
(RP-HPLC) disaccharide analysis
Cells were plated in T175 flasks, grown to 80–90% confluency
and detached using ethylenediaminetetraacetic acid (EDTA) and a
police man scraper to harvest extracellular matrix components.
The preparation was incubated with chondroitinase-ABC (Sigma
Aldrich, St. Louis, USA) in digestion buffer (250 mM Tris, 20 mM
MgAc2, pH 8.0) at a final concentration of 1 IU/ml (37uC, 24 h).
Samples were vacuum dried and reconstituted with 0.1 M
aminoacridone (AMAC) solution in glacial acetic acid/DMSO
(3:17, v/v). 1 M NaCNBH3 was added and the samples were
incubated for 6 h at 45OC. Finally, 50% (v/v) dimethyl sulfoxide
was added and the samples were stored at 280OC. The final
disaccharide composition of CS was evaluated by quantitative
analysis of the AMAC labeled digests using RP-HPLC. A gradient
elution was performed using a binary solvent system as described
by Ambrosius et al [33]. Equilibration of the Waters X-Bridge
Shield column (10064.6 mm ID) took place with 98% 60 mM
ammonium acetate (NH4Ac), pH 5.6 and 2% acetonitril for
7 min. After injection of the samples the following program was
used: 1 min at equilibration condition, a linear gradient step to 4%
acetonitril in two min, a separation gradient step to 15%
acetonitril in 23 min, a washing step in 1 min to 60% acetonitril
followed by another 5 min at 60% and returning to equilibration
conditions in 1 min. Flow rate was 1.5 ml/min and monitoring
was performed with a fluorescence detector (lex 442 nm, lem
520 nm).
2D scratch assay
For 2D-migration analysis a scratch assay was applied.
Transfected and not-transfected SKOV3 cells were detached by
EDTA, resuspended in DMEMmedium containing 10% FCS and
plated onto 12-well plates (56104 per well). Cells were grown to
confluency and subsequently starved in a serum free DMEM
medium for 24 hrs. After starvation, one artificial gap (scratch) was
made using a sterile plastic 10 ml micropipette tip. Next, tissue
culture medium was removed and cells were washed in sterile PBS
to eliminate detached cells and debris. Experiments were
performed by incubating the cells with normal medium or normal
medium supplemented with CSE (Seikagaku, Tokyo, Japan) (50
and 100 mg/ml). Cell migration was monitored taking digital
photographs at different time-points with a phase contrast
microscope. All experiments were performed three or more times.
Spheroid formation, the ‘hanging’- drop method
In accordance with the predominant metastatic pattern of
ovarian carcinomas in the abdomen, we studied SKOV3 cell
behavior not only as single cells but also as tumour cell aggregates
(spheroids). Multicellular spheroids are thought to represent an
important way for tumour dissemination in ovarian cancer. In
addition, compact spheroid formation provides a protective shield
for tumour cells. For that purpose, cells from subconfluent cultures
were detached with 2 mM EDTA and multicellular spheroids
were generated using the hanging-drop method [34]. In brief, cells
were resuspended in DMEM growth medium supplemented with
10% methylcellulose to a final cell concentration of646104 cells/
ml and incubated in hanging droplets (25 ml) overnight. After cell
aggregation, spheroids were washed in phosphate buffered saline
(PBS) and used for migration assays. To further study the adhesive
properties of CS wildtype SKOV3 cells in hanging drops were
digested with specific glycosaminoglycan degrading enzymes
including chondroitinase ABC (Sigma Aldrich, St. Louis, USA),
chondroitinase B and chondroitinase AC (IBEX Technologies,
Montreal, Canada).
Spheroid cell migration in 3-D collagen matrices
Spheroids (616103 cells) prepared from different SKOV3
clones were incorporated into 3D collagen matrices as described
before [35,36]. In brief, SKOV3 spheroids were suspended in a
solution containing 1.6 mg/ml bovine collagen type I (Inamed
Biomaterials, Fremond, CA), 7% minimal essential medium and
3% bicarbonate in DMEM. The mix was gently transferred into a
6 well plate and allowed to polymerize for 20–30 minutes in an
incubator at 37uC with 5% CO2. After polymerization the freshly
prepared gels were covered with DMEM medium.
To study the influence of CSE on tumour cell migration, a
protocol for CS decoration of the fibrillar type I collagen was
developed. For this, an intermediate step was incorporated in
which CSE (final concentration either 50 or 100 ug/ml) was
added to the MEM bicarbonate suspension prior to collagen
addition ((S2A). Inclusion of this step resulted in collagen fibrils
associated with (FITC-labeled) CSE (AMS biotechnology, Abing-
ton UK), as demonstrated with confocal microscopy (S2B). To our
knowledge, this is the first time a complex re-assembled meshwork
of collagen fibrils homogeneously decorated with a negatively
charged glycosaminoglycans is visualized. SKOV3 cell migration
was microscopically recorded with an inverted microscope (Leitz
Fluovert, Cologne, Germany) at 37uC and photographs were
Table 1. General patient characteristics.
Panel (n =25)
Age (median, range) 57 (23–84)
CA125 at diagnosis (median, range) 433.9 (53.9–8203.0)
Menopausal status
Pre- 9
Post- 16
FIGO
I -
II 2
III 20
IV 2
Unknown 1
Grade
I -
II 2
III 23
Primary cytoreductive surgery
Complete 9
Incomplete 14
Not reported 2
doi:10.1371/journal.pone.0111806.t001
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taken at time points 0, 12 and 24 hrs. All experiments were
performed three or more times.
Cell viability was checked for single cells contained in DMEM
supplemented with 50 or 100 mg/ml CSE using WST-1 analysis
and cell counting based on nigrosin staining. Both CSE
concentrations did not significantly affect cell viability (data not
shown).
Results
Chondroitin sulfate expression in primary and secondary
ovarian tumours
The clinical characteristics of the patient panel are summarized
in table 1. Median age at the time of diagnosis was 57 (range 23–
84) and the majority of women was postmenopausal. Our study
panel consisted solely of patients suffering from high grade (II–III),
serous ovarian carcinomas.
CS and DS are present throughout both the tumoural and non-
tumoural stroma. This was demonstrated using antibodies
IO3H10 (overall CS staining) and GD3A12 (overall DS staining)
(fig. 1B and C) [11,30]. We also applied antibody GD3G7 which
defines a specific epitope harboring contiguous 4,6 disulfated
(CSE) disaccharide units, a rare CS modification. In accordance
with our previous studies [19,31], GD3G7 expression in ovarian
carcinomas was predominantly seen in the intratumoural stroma,
the basement membrane zone underlying tumour cells, and the
region surrounding (pathological) blood vessels. A CSE gradient
was seen at places where tumour tissue is adjacent to non-
tumourous tissue (fig. 1D and E).
In general, primary ovarian tumours and abdominal secondary
tumours showed a similar staining pattern. Both intensity and
extent of CSE staining were comparable. In figure 2 GD3G7
epitope expression is shown for a primary tumour (fig. 2A), and
three secondary metastatic tumour depositions, one on the
contralateral ovary (fig. 2B), one in the omentum (fig. 2C) and
one in the Douglas pouch’ (fig. 2D). All metastatic localizations
were strongly positive for the GD3G7 epitope. Again, GD3G7
expression was predominantly present in the intratumoural
stroma, the stroma directly surrounding tumour depositions, and
small (tumour) blood vessels. When the mesothelial lining and its
underlying basement membrane were associated with tumour
cells, an evident strong staining with GD3G7 was seen (arrow
fig. 2B).
Expression of chondroitin sulfate-E by SKOV3 cells
transfected with DNA encoding GalNAc4S-6STGalNAc4S-
6ST
To study the effect of CSE on tumour cell behavior we
transfected cells with DNA encoding GalNAc4S-6ST, the enzyme
involved in the biosynthesis of 4,6-disulfated disaccharides. We
selected three stably transfected clones with the vector containing
GalNAc4S-6ST and two clones containing an empty vector.
These cell lines and wild-type SKOV3 cells were analysed for the
presence of CSE using antibody GD3G7 and by disaccharide
analysis of CS.
Using confluent cells, the wildtype SKOV3 cells as well the cells
containing the empty vector showed weak to moderate (peri)cel-
lular staining with antibody GD3G7 (fig. 3A–C), whereas cells
transfected with the DNA encoding GalNAc4S-6ST showed more
abundant staining, including areas of very strong staining intensity
(fig 3D–F).
To analyse the disaccharide composition of CS we applied RP-
HPLC with AMAC labelling. This technique allows separation
and quantification of 8 different CS disaccharides based on their
degree of sulfation. Overall, SKOV3 wildtype and empty vector
clones were comparable for their CS disaccharide composition,
including the CSE (4,6-di sulfated disaccharide) unit. When the
CS disaccharide composition of full vector cell lines was compared
with the control cell lines, CSE content was significantly elevated
(p-value = 0.026) (fig. 4), which was in line with the increased
staining by GD3G7 (fig. 3). In addition, there was a tendency
(p = 0.081), for a decrease in CSA disaccharide units (4S), which is
the substrate of GalNAc4S-6ST.
Chondroitin sulfate (E) provides adhesive properties
Strong adhesive properties are an important survival tool of
tumours. To investigate the role of CS in this respect, we prepared
spheroids, cell aggregates often associated with tumour metastasis.
Wildtype SKOV3 cells in hanging drops were digested with
specific glycosaminoglycan degrading enzymes including chon-
droitinase ABC (cleaves both CS and DS), chondroitinase B
(cleaves DS) and chondroitinase AC (cleaves CS). When either of
chondroitinase ABC or AC was added, spheroid formation was
inhibited for approximately 48 hours (fig. 5A). After 48 hours this
effect disappeared, likely because of reduced enzyme activity. By
contrast, chondroitinase B did not influence cell aggregation.
Indicating that spheroid formation is CS but not DS dependent.
To study the specific effect of CSE on spheroid formation,
spheroids prepared from cells overexpressing CSE were evaluated.
Figure 1. Strong staining for CSE in tumours. Sections of paraffin
embedded primary serous ovarian carcinoma were stained for CS, DS
and CSE using antibodies IO3H10, GD3A12 and GD3G7, respectively. A)
Haematoxylin-Eosin staining showing tumourous versus non-tumour-
ous regions. Non-tumourous regions are indicated with an asterix (*). B–
E) Overall staining for CS (B: antibody IO3H10), DS (C:antibody GD3A12)
and CSE (D, E antibody GD3G7). Note overall staining for CS and DS, but
strong CSE staining in intratumoural stroma, including small tumour
capillaries (E, arrows). Also note mild staining of large blood vessels in
non-tumourous areas (E) Staining for CSE indicated a gradient of CSE at
the boundary of tumour and non-tumourous tissue (**). Bar: 100 mm.
doi:10.1371/journal.pone.0111806.g001
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In comparison with to spheroids prepared from wild type cells or
empty vector cells, CSE overexpressing spheroids displayed a
more roundish appearance and showed a more smooth surface
(fig. 5B), suggesting a more firm attraction of cells.
Chondroitin sulfate E reduces cell migration
Since cell migration is an intermediate step in the metastatic
process of ovarian cancer, the role of CSE was examined in 2D
and 3D migration assays. We studied the migrative properties of
wildtype and transfected SKOV3 cells in a 2D system using a
scratch assay (fig. 6). Both wildtype SKOV3 cells and SKOV3
cells containing the empty vector closed the artificial wound within
24 hours. SKOV3 cells overexpressing CSE did not (fig. 6A).
These cells closed the gap approximately 12 to 24 hours later. An
inhibitory effect on migration was also seen when CSE was
supplemented to the culture medium of wildtype SKOV3 cells
(fig. 6B).
To study the effect of CSE on cell migration in 3D systems,
spheroids were prepared from wildtype and transfected SKOV3
cells and embedded in a collagenous matrix. Wildtype SKOV3
cells migrated out of the spheroid primarily as single cells and
sometimes following collective strand formation. The same was
seen for spheroids prepared from SKOV3 cells harboring an
empty vector. However, SKOV3 cells overexpressing CSE were
hardly able to migrate out of the spheroid, nor as single cells, nor
as collective strands (fig. 7A). In an alternative approach, we
prepared collagenous matrices in the presence of CSE, resulting in
collagen fibrils associated with CSE. In such matrices wildtype
SKOV3 cells showed very restricted cell migration (fig. 7B),
further indicating the cell migrative inhibiting effect of CSE.
Discussion
High lethality in ovarian cancer is primarily due to rapid
metastasis of the tumour. In this study we observed manifest
presence of CSE, a CS harbouring 4,6-disulfated disaccharides, in
both primary and metastatic ovarian tumours, and we propose a
functional role for CSE in tumour cell adhesion in ovarian cancer
spheroids.
CS likely possesses a number of roles in the micro-environment
of (tumour) cells and upregulation of highly sulfated CS (such as
CSE) has been described for various tumours. Through the
binding of glycosaminoglycans with effector molecules such as
cytokines, chemokines, and growth factors [37], chondroitin
sulfates (especially CSE) are able to regulate many cellular
mechanisms in both physiological and pathological conditions,
including proliferation and angiogenesis. The metastatic cascade
involves detachment, adhesion and migration/invasion, and
encompasses various interactions between tumour cells and
components of the ECM [38].
Ovarian cancer dissemination predominantly occurs via intra-
abdominal spread of the tumour. Exfoliated tumour cells are
carried via peritoneal fluid or ascites to secondary sites in the
abdominal cavity [39]. Spheroid formation may represent an
important intermediate survival mechanism facilitating ovarian
cancer dissemination. Compact formation of spheroids by ovarian
cancer cells has been associated with more aggressive and invasive
characteristics [40,41]. In addition, decreased penetrance of
immune cells and therapeutics provides spheroids with an
important advantage for survival [42]. In this study, we found
that CS has a role in spheroid formation, and overexpression of
CSE disaccharide units improves the adhesive properties of
tumour cells. Our results are in line with the finding that down-
regulating of GalNAc4S-6ST in Lewis lung carcinoma cells
Figure 2. Strong staining for CSE in transcoelomic, ovarian
metastasis (antibody GD3G7). A) Primary tumour, B) contralateral
ovary, C) omentum, D) Douglas’ pouch all displayed strong staining for
CSE. Note the staining at sites where the mesothelial lining and its
underlying basal membrane were associated with intruding tumour
cells (B, arrow). Bar: 100 mm.
doi:10.1371/journal.pone.0111806.g002
Figure 3. Increase of staining for CSE in SKOV3 cells
transfected with GalNAc4S-6ST (antibody GD3G7). SKOV3 wild-
type (A) and transfection control (empty vector) SKOV3(-) cells (C5 (B)
and C6 (C)) showed weak (peri)cellular expression of CSE, whereas
SKOV3 cells transfected with DNA encoding GalNAc4S-6ST (F5(D), F7(E),
F9(F)) showed strong expression for CSE expression, especially in more
dense regions. Bar: 100 mm.
doi:10.1371/journal.pone.0111806.g003
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Figure 4. Reversed phase high performance liquid chromatography (RP-HPLC) for CS disaccharides. Chondroitin sulfate disaccharide
composition of wild type, cells transfected with an empty vector (C5, C6), and cells transfected with a vector containing GalNAc4S-6ST (F5, F7, F9).
Significantly higher CSE disaccharide content (*) was found in cells transfected with GalNAc4S-6ST (one-way ANOVA; level of significance p,0.05).
doi:10.1371/journal.pone.0111806.g004
Figure 5. Spheroid formation by SKOV3 cells depends on chondroitin sulfate. A) Spheroid formation (tumour cell aggregation) was
inhibited by enzymatic digestion using either of chondroitinase-ABC or –AC but not by chondroitinase B. Bar: 200 mm B) Spheroids formed by wild
type SKOV3 cells and cells transfected with GalNAc4S-6ST and empty vector. Note the smooth and roundish appearance of GalNAc4S-6ST transfected
cells. Bar: 100 mm.
doi:10.1371/journal.pone.0111806.g005
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PLOS ONE | www.plosone.org 6 November 2014 | Volume 9 | Issue 11 | e111806
reduced adhesion and restricted the formation of novel tumor
noduli [27]. Like lung cancer, the majority of malignant tumours
spread through hematogenous or lymphogenous pathways, and
upregulation of CSE may play a role. Blood born metastatic
tumour cells with adhesive properties are more likely to develop
tumour noduli at secondary sites. In addition, the formation of a
physical barrier (pericellular matrix containing CSE) may provide
a protective environment against the immune system and
chemotherapy.
In vivo, CSE expression is predominantly seen in the stromal
compartment of both primary ovarian carcinomas and metastasis.
The stromal compartment is actively involved in tumour
progression and metastasis. The presence of large intratumoural
stroma areas has been correlated with poor prognosis in ovarian
cancer patients [43]. Tumour cells create a tumour-facilitating
micro-environment by altering the pre-existent stroma. In
addition, tumour cells create ECM during spheroid formation
[44]. CS, as part of the tumour micro-environment, accumulates
in the stromal compartment of many solid tumours, including
ovarian carcinoma [13,45]. The ‘‘seed and soil’’ hypothesis
proposes that an appropriate host micro-environment (the soil) is
needed for the optimal growth and spread of tumour cells (the
seed) [46]. Recently, it was suggested that tumour cells might bring
their own soil [8]. For this matter, spheroids may provide the ideal
vehicle to bring soil (metastatic niche) to a secondary tumour site.
This metastatic niche includes ECM components, growth factors
and activated fibroblasts (CAFs), all active facilitators for tumour
growth and metastasis formation [8]. Identifying adhesion
molecules that are responsible for adherence (such as CSE)
between cancer cells, stroma and CAFs may provide new targets
for anti-metastasis therapy.
Strong CSE expression was observed at the ‘‘invasion front’’ of
metastatic lesions (fig. 2). The upregulation of CSE at the
secondary site may be a tumour cell induced modification of host
cell ECM in such a way that it presents the appropriate soil for
tumour growth and angiogenesis. The binding properties of CSE
for a large variety of tumour associated growth factors such as
FGF2 and VEGF, but also important adhesion molecules
including N-cadherin and E-cadherin may be instrumental in this
regard. [47,48] In addition, CSE may be one of the adhesion
molecules involved in the adherence between cancer cells and
stroma. It was shown that pretreatment of ovarian cancer cells
with the chondroitin sulfate cleaving enzyme chondroitinase ABC
decreased cell adhesion to the ECM proteins fibronectin, type IV
collagen and laminin, and mesothelial cells [49,50].
Although tumour cells are the prime targets of cytostatic
therapy, the tumour stroma has been suggested as an attractive
target for cancer treatment as well. CSE, which is accumulated in
tumour stroma, could be a specific target in this respect. Blockage,
inhibition or enzymatic degradation of CSE could interfere with
tumour cell aggregation, growth factor binding, and metastasis.
Enzymatic degradation of CS by chondroitinase AC has been
shown to inhibit melanoma proliferation and invasion [51].
However, conflicting data are available to the effect of enzymatic
degradation of all chondroitin and dermatan sulfate by intra-
tumoral injections of chondroitinase ABC. For instance, enzymatic
degradation of all CS/DS by intra-tumoural injections of
chondroitinase ABC results in the development of secondary
tumours and increased lung metastases [52]; in solid Ehrlich
ascites tumors, however, growth was restricted after chondroiti-
nase ABC injection [53]. This suggests that targeting specific
Figure 6. CSE inhibits artificial wound closure in 2D scratch assays. A) Wildtype SKOV3 cells and cell transfected with empty vector closed
the artificial wound within 24 hours, whereas cells transfected with GalNAc4S-6ST cells did not. B) Addition of CSE to wildtype SKOV3 cells inhibited
cell migration, showing limited gap-closure after 24 hours. Bar: 200 mm.
doi:10.1371/journal.pone.0111806.g006
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chondroitin sulfates, rather than all of them, is key to a potential
anti-tumour strategy.
The data presented here indicate that a specific 4,6-disulfated
CS motif (CSE) is associated with metastatic lesions and that this
structural motif provides tumours with adhesive properties. If
specifically addressed, the CS motif may be a potential target for
ovarian cancer therapy.
Supporting Information
Information S1 Cloning strategy to obtain GalNAc4S-
6ST containing pIRES2-EGFP plasmid. A) pFLAG-CMV2-
hGalNAc4S-6ST plasmid was double digested with restriction
enzymes EcoRI and HindIII to obtain the GalNAc4S-6ST insert.
The pBluescript SK II (-) vector was double digested with
restriction enzymes EcoRI and HindIII, and the GalNAc4S-6ST
insert was ligated vector, generating an intermediate vector. B)
The intermediate vector and the pIRES2-EGFP plasmid were
double digested with restriction enzymes EcoRI and IXhoI, and
GalNAc4S-STt ligated into the pIRES2-EGFP plasmid.
(TIF)
Information S2 Generation of 3D collagen matrices with
homogeneously coated chondroitin sulfate E chains, and
culturing of SKOV3 spheroids for cell migration studies.
A) The spheroids were embedded into a matrix of type I collagen
as described previously [54], but with an additional step for
administration of the chondroitin sulfate E (CSE, 1 mg/ml) into
the minimum essential medium (MEM)/bicarbonate (BIC)
solution before adding the bovine type I collagen. SKOV3
spheroids in DMEM medium were transfered into the collagen I/
chondroitin sulfate E solution reaching a final concentration of
collagen-spheroid suspension of 1.67 mg/mI. The suspension was
quickly pre-polymerized for 5 minutes at 37uC, 5% CO2 and
eventually allowed to polymerize at 37uC for 20–30 min (5% C02)
in a self-constructed cell migration chamber [54]. The type I
collagen–chondroitin sulfate matrices were analyzed by using an
Figure 7. CSE inhibits SKOV3 cell migration out of spheroids in 3D collagen matrices. A) Wildtype and cells transfected with an empty
vector (-) showed cell migration out of spheroids, whereas migration of cells transfected with GalNAc4S-6STwas almost absent. B) Strong restriction of
migration of wildtype SKOV3 cells out of spheroids in CSE decorated collagen matrices. Bar: 200 mm.
doi:10.1371/journal.pone.0111806.g007
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Olympus FV1000 confocal laser scanning microscope excitation at
488 nm and emission detection of 520/50 nm (for FITC-labeled
chondroitin sulfate) and confocal reflection contrast was used for
detection of collagen fibers. For that, laser light (633 nm) at a low
intensity was introduced into the sample. B) Confocal microscopy
showing matrix decoration with chondroitin sulfate E (CSE).
Upper row; non-decorated type I bovine collagen matrix. Left:
Collagen reflection (white), middle: Background (green (FITC)
channel), right: Overlay of reflection and background signal.
Lower row; CSE-decorated bovine collagen I matrix. Left:
Collagen reflection, middle: CSE-FITC (green (FITC) channel),
right: Overlay of reflection and CSE signal.
(TIF)
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